UPS Healthcare Logistics adds prequalified packages to its cold chain services
Service eases the management of domestic US shipments to trading partners and patients
Offering to streamline the cold chain delivery-selection process while providing economies of scale through standardized configurations, UPS Healthcare Logistics is now marketing four packaging lines (Med 100, 200, 300 and 400), each with a range of sizes and options for temperature-controlled duration. The packaging (which is delivered to the shipper) also aligns with UPS’ Temperature True service options, which allow for preselected overnight, two-day or other delivery options. “Healthcare customers benefit from more expertise and options created to minimize costs and maximize efficiency when time and temperature control is the highest priority,” said John Menna, UPS VP of global strategy, healthcare logistics, in a statement.
The range of sizes and temperature control covers many applications in clinical trials, diagnostic specimens, direct-to-patient or —physician deliveries of single doses, and commercial-scale shipments. Capacities range from 1.2 to 39.6 liters. Temperature regimes cover frozen (
UPS Healthcare Logistics has had a packaging-design and validation lab for years; that capability enables the company to assist clients with the qualification steps necessary for regulatory approvals, says Menna. It is also being extended to UPS clients outside the US.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
